Patents not ‘limiting factor’ for vaccine production: BioNTech
German firm BioNTech said Thursday that patent protection for COVID-19 vaccines is not holding back production or supply of the jabs that it developed with Pfizer.
- Next story The Division getting a standalone free-to-play game called Heartland
- Previous story Mayo Clinic Minute: Lifestyle changes to manage menopause symptoms
Explore more
- Sign Up: ‘On Politics’
Your guide to the political news cycle, delivering clarity from the chaos. - Glimpses of a Soviet Ghost Town on an Arctic Norwegian Isle
On the remote archipelago of Svalbard, a decaying settlement offers visitors an... - Best Prime Day Razer deals for 2021
Gamers should never pass up on the chance to upgrade their devices... - Exclusive: The 27-year-old behind ethereum isn’t surprised by the crypto crash
The crypto crash of the past few days has shocked investors around... - How social isolation can harm health as you age – and how to prevent it
Barbara Stopfer hasn’t had much of a social life since her husband... - St. Vincent suffers power outage after La Soufrière volcano erupts
There has been a massive power outage on the Caribbean island of... - The best headphones for 2021
From waterproof true wireless headphones to over-the-ear cans with active noise cancellation,... - 3D genome structure influences cancer
For the first time, scientists have examined how the three-dimensional (3D) structure... - Elon Musk on Mars: ‘You might not come back alive.’
There may not be a bigger promoter of the idea that humanity... - The potential role of vaccine certificates in the next phase of the pandemic
The CDC says that fully vaccinated individuals can resume many day-to-day activities...